Table 2.
Baseline characteristics at study entry for 39,815 women free of cardiovascular disease and heart failure at baseline
| Characteristic | Vitamin E (n=19913) |
Placebo (n=19902) |
|---|---|---|
| Age, % | ||
| 45–54 y | 60.3 | 60.3 |
| 55–64 y | 29.5 | 29.5 |
| >=65 y | 10.2 | 10.3 |
| Non-Hispanic White race/ethnicity, % | 94.7 | 94.9 |
| Hypertension, % | 25.6 | 26.1 |
| Hypercholesterolemia, % | 29.3 | 29.6 |
| Diabetes, % | 2.9 | 2.8 |
| Smoking, % | ||
| Current smoking | 13.0 | 13.3 |
| Past smoking | 36.1 | 35.6 |
| Never smoking | 51.0 | 51.2 |
| Body mass index, % | ||
| <25.0 kg/m2 | 50.5 | 50.8 |
| 25.0–29.9 kg/m2 | 31.2 | 30.9 |
| >=30 kg/m2 | 18.3 | 18.3 |
| Menopausal status and hormone therapy use, % | ||
| Premenopausal | 27.5 | 27.8 |
| Uncertain/perimenopausal | 17.9 | 18.0 |
| Postmenopausal and current hormone therapy | 30.1 | 30.0 |
| Postmenopausal and no hormone therapy | 24.5 | 24.2 |
| Physical activity (at least 1000 kcal/week in leisure-time activities) | 33.7 | 34.2 |
| Alcohol consumption (at least 1 drink per month), % | 54.6 | 55.3 |
| Multivitamin use, % | 39.2 | 38.4 |
| Aspirin assignment, % | 50.0 | 50.0 |
| Beta carotene assignment, % | 50.0 | 50.0 |